Physician Wealth Advisors
RYTM icon

Physician Wealth Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History

Physician Wealth Advisors’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.19K Buy
23
+7
+44% +$747 ﹤0.01% 1529
2026
Q2 		$1.78K Hold
16
– – ﹤0.01% 1551
2026
Q1 		$1.39K Hold
16
– – ﹤0.01% 1510
2025
Q4 		$1.71K Hold
16
– – ﹤0.01% 1359
2025
Q3 		$1.62K Hold
16
– – ﹤0.01% 1319
2025
Q2 		$1.01K Buy
+16
New +$980 ﹤0.01% 1417

Other funds holding RYTM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Picton Mahoney Asset Management
Picton Mahoney Asset Management Toronto, Ontario, Canada $14.8B AUM 38.11% 1-Year Est. Return

Physician Wealth Advisors's RYTM Position: Q3 2026 in Review

Physician Wealth Advisors increased its Rhythm Pharmaceuticals (RYTM) stake by 44% in Q3 2026, buying an estimated $747 and bringing the position to 23 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1529.

Physician Wealth Advisors first reported a position in RYTM in Q2 2025 and has held it in 6 quarters since. 120 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Physician Wealth Advisors held 23 shares of Rhythm Pharmaceuticals worth $2.19K as of Q3 2026.
  • Physician Wealth Advisors bought 7 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $747.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #1529 holding.
  • Physician Wealth Advisors first reported a position in Rhythm Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • 120 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.